MKKGY Merck KGaA

OTC
$32.83

Merck KGaA (MKKGY) is expected to report earnings on February 11, 2027, before the market open. The consensus earnings estimate is $0.43 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.2% since its last earnings release on November 12, 2026.

Merck KGaA Missed Consensus Estimates
Thursday, November 12, 2026 · 12:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · Before Open
Earnings Whisper
-
vs $0.43
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $32.81

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Merck KGaA

Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.